- Home
- LDI vs VYGR Comparison
LDI vs VYGR Comparison
Compare LDI & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDI
- VYGR
- Stock Information
- Founded
- LDI 2010
- VYGR 2013
- Country
- LDI United States
- VYGR United States
- Employees
- LDI N/A
- VYGR N/A
- Industry
- LDI Finance: Consumer Services
- VYGR Biotechnology: Pharmaceutical Preparations
- Sector
- LDI Finance
- VYGR Health Care
- Exchange
- LDI Nasdaq
- VYGR Nasdaq
- Market Cap
- LDI 402.7M
- VYGR 386.1M
- IPO Year
- LDI 2021
- VYGR 2015
- Fundamental
- Price
- LDI $2.73
- VYGR $7.00
- Analyst Decision
- LDI Sell
- VYGR Strong Buy
- Analyst Count
- LDI 3
- VYGR 7
- Target Price
- LDI $2.10
- VYGR $17.43
- AVG Volume (30 Days)
- LDI 805.2K
- VYGR 677.7K
- Earning Date
- LDI 11-05-2024
- VYGR 11-12-2024
- Dividend Yield
- LDI N/A
- VYGR N/A
- EPS Growth
- LDI N/A
- VYGR N/A
- EPS
- LDI N/A
- VYGR 0.18
- Revenue
- LDI $977,737,000.00
- VYGR $143,769,000.00
- Revenue This Year
- LDI N/A
- VYGR N/A
- Revenue Next Year
- LDI $24.29
- VYGR N/A
- P/E Ratio
- LDI N/A
- VYGR $40.04
- Revenue Growth
- LDI 18.95
- VYGR N/A
- 52 Week Low
- LDI $1.35
- VYGR $5.71
- 52 Week High
- LDI $3.71
- VYGR $11.72
- Technical
- Relative Strength Index (RSI)
- LDI 68.86
- VYGR 53.18
- Support Level
- LDI $2.04
- VYGR $6.40
- Resistance Level
- LDI $2.25
- VYGR $7.23
- Average True Range (ATR)
- LDI 0.12
- VYGR 0.45
- MACD
- LDI 0.07
- VYGR -0.01
- Stochastic Oscillator
- LDI 93.29
- VYGR 48.31
About LDI loanDepot Inc.
loanDepot Inc provides nonbank consumer lending solutions for individuals in the United States. It offers personal, residential home, home refinancing, mortgage and home equity loans. It also provides online mortgage loans for refinancing and home purchases. It serves customers through distribution channels, including consumer direct centres, retail branches, wholesale centres, and consumer finance and servicing centres in the United States. It competes with commercial banks and financial institutions.
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.